K
Klaus P Machold
Researcher at Medical University of Vienna
Publications - 108
Citations - 10209
Klaus P Machold is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Rheumatoid arthritis & Arthritis. The author has an hindex of 46, co-authored 105 publications receiving 9542 citations. Previous affiliations of Klaus P Machold include Ludwig Maximilian University of Munich & University of Vienna.
Papers
More filters
Journal Article
Musculoskeletal ultrasound including definitions for ultrasonographic pathology
Richard J. Wakefield,Peter V. Balint,Marcin Szkudlarek,Emilio Filippucci,Marina Backhaus,Maria Antonietta D'Agostino,Esperanza Naredo Sanchez,Annamaria Iagnocco,Wolfgang A. Schmidt,George A W Bruyn,David Kane,Philip O'Connor,Bernhard Manger,Fred Joshua,Juhani M. Koski,Walter Grassi,Marissa Lassere,Nanno Swen,Franz Kainberger,Andrea Klauser,Mikkel Østergaard,Andrew K. Brown,Klaus P Machold,Philip G. Conaghan +23 more
TL;DR: The first report from the OMERACT ultrasound special interest group is presented, which has compared US against the criteria of the O MERACT filter, and for the first time are consensus US definitions for common pathological lesions seen in patients with inflammatory arthritis.
Journal ArticleDOI
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
Daniel Aletaha,Valerie Nell,Tanja Stamm,Martin Uffmann,Stephan Pflugbeil,Klaus P Machold,Josef S Smolen +6 more
TL;DR: A purely clinical score is a valid measure of disease activity and will have its greatest merits in clinical practice rather than research, where APRs are usually always available.
Journal ArticleDOI
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Bernard Combe,Robert Landewé,Cédric Lukas,Horatio D Bolosiu,F. C. Breedveld,Maxime Dougados,Paul Emery,Gianfranco Ferraccioli,Jmw Hazes,Lars Klareskog,Klaus P Machold,Emilio Martín-Mola,Henrik Nielsen,Alan J. Silman,Josef S Smolen,Hasan Yazici +15 more
TL;DR: 12 key recommendations for the management of early arthritis or early rheumatoid arthritis were developed, based on evidence in the literature and expert consensus, in accordance with EULAR's "standardised operating procedures".
Journal ArticleDOI
Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis
TL;DR: There is a window of opportunity for highly successful treatment of RA in the first year, and especially within the first 3 months of therapy, indicating that early diagnosis and therapy may be the crucial step in achieving optimal control of disease progression and prognosis in RA.
Journal ArticleDOI
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial
J.M. van Laar,Dominique Farge,Jacob K. Sont,Kamran Naraghi,Zora Marjanovic,Jérôme Larghero,Annemie J. Schuerwegh,Erik W.A. Marijt,Madelon C. Vonk,Anton Schattenberg,Marco Matucci-Cerinic,A E Voskuyl,A.A. van de Loosdrecht,Thomas Daikeler,Ina Kötter,Marc Schmalzing,Thierry Martin,Bruno Lioure,S.M. Weiner,Alexander Kreuter,Christophe Deligny,Jean-Marc Durand,Paul Emery,Klaus P Machold,F. Sarrot-Reynauld,Klaus Warnatz,Daniel Adoue,Joël Constans,Hans-Peter Tony,N. Del Papa,A Fassas,Andrea Himsel,David Launay,A. Lo Monaco,P. Philippe,Isabelle Quéré,E. Rich,Rene Westhovens,Bridget Griffiths,Riccardo Saccardi,F.H.J. van den Hoogen,Willem E. Fibbe,Gérard Socié,Alois Gratwohl,Alan Tyndall +44 more
TL;DR: Among patients with early diffuse cutaneous systemic sclerosis, HSCT was associated with increased treatment-related mortality in the first year after treatment, however, HCST conferred a significant long-term event-free survival benefit.